Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-28T23:50:56.716Z Has data issue: false hasContentIssue false
  • English
  • Français

Reply to Dr. Ellen Burgess

Published online by Cambridge University Press:  01 January 2021

Kathleen Cranley Glass
Kathleen Cranley Glass*
Affiliation:
Dept. of Human Genetics and Ctr. for Medicine, Ethics and Law, McGill University, Montreal, Quebec
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Journal of Law, Medicine & Ethics , Volume 23 , Issue 2 , Summer 1995 , pp. 212
Copyright
Copyright © American Society of Law, Medicine and Ethics 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Relman, A.S., “More on the Ingle-finger Rule,” N. Engl. J. Med., 318 (1988): at 1125; Lundberg, G.D., Glass, R.M., Joyce, L.E., “Policy of AMA Journals Regarding Release of Information to the Public,” JAMA, 265 (1991): at 400; and Fletcher, S.W., Fletcher, R.H., “Early Release of Research Results,” Ann. Int. Med., 114 (1991): 698–700.Google Scholar
See supra note 1.Google Scholar
Friedman, M.A., “The Clinical Announcement Policy of the National Cancer Institute,” in Williams, C.J., ed., Introducing New Treatments for Cancer: Practical, Ethical and Legal Problems (Chichester: John Wiley, 1992): at 414.Google Scholar
See Fletcher, and Fletcher, , supra note 1.Google Scholar